Appleby Advises Frazier Life Sciences Acquisition Corp. II on Its USD75M Initial Public Offering
Appleby is pleased to announce that it acted as Cayman Islands legal counsel Frazier Life Sciences Acquisition Corp. II in connection to its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares began trading on the Nasdaq Capital Market on October 14, 2026, and are listed under the ticker symbol “FLSC.”
Frazier Life Sciences Acquisition Corp. II is sponsored by Frazier Life Sciences, a longstanding biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.
The Appleby Capital Markets team was led by Cayman Islands Partner Alexandra Low, and included, BVI Partner James Kitching, Hong Kong Senior Associate Alejandra Saucedo Gonzalez, Cayman Islands Paralegal Sophia Cunningham and Articled Clerk Emily McIntyre alongside other members of the corporate team.
Appleby continues to play a key role in major IPO and public-market matters worldwide.
